43857-0527 NDC - RENOTOX (TRITICUM AESTIVUM, ASPARAGUS OFFICINALIS, BERBERIS VULGARIS, ECHINACEA (ANGUSTIFOLIA), KALI MURIATICUM, PETROSELINUM SATIVUM, SABAL SERRULATA, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, UVA-URSI, BAROSMA (BETULINA), EUPATORIUM PURPUREUM, KIDNEY (SUIS), BRYONIA (ALBA), MERCURIUS CORROSIVUS, ALUMINUM METALLICUM, ANTIMONIUM CRUDUM, ARGENTUM METALLICUM, ARSENICUM ALBUM, AURUM METALLICUM, BARYTA CARBONICA, BERYLLIUM METALLICUM, BISMUTHUM METALLICUM, BORON, BROMIUM, CADMIUM METALLICUM, CERIUM METALLICUM,)

Drug Information

Product NDC: 43857-0527

Proprietary Name: Renotox

Non Proprietary Name: Triticum Aestivum, Asparagus Officinalis, Berberis Vulgaris, Echinacea (Angustifolia), Kali Muriaticum, Petroselinum Sativum, Sabal Serrulata, Solidago Virgaurea, Taraxacum Officinale, Uva-Ursi, Barosma (Betulina), Eupatorium Purpureum, Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum,

Active Ingredient(s):
  • 5 [hp_X]/mL AGATHOSMA BETULINA LEAF;
  • 12 [hp_X]/mL ALUMINUM;
  • 12 [hp_X]/mL ANTIMONY TRISULFIDE;
  • 3 [hp_X]/mL ARCTOSTAPHYLOS UVA-URSI LEAF;
  • 12 [hp_X]/mL ARSENIC TRIOXIDE;
  • 3 [hp_X]/mL ASPARAGUS;
  • 12 [hp_X]/mL BARIUM CARBONATE;
  • 3 [hp_X]/mL BERBERIS VULGARIS ROOT BARK;
  • 12 [hp_X]/mL BERYLLIUM;
  • 12 [hp_X]/mL BISMUTH;
  • 12 [hp_X]/mL BORON;
  • 30 [hp_X]/mL BOTULINUM TOXIN TYPE A;
  • 12 [hp_X]/mL BROMINE;
  • 12 [hp_X]/mL BRYONIA ALBA ROOT;
  • 12 [hp_X]/mL CADMIUM;
  • 12 [hp_X]/mL CERIUM;
  • 12 [hp_X]/mL CESIUM CHLORIDE;
  • 12 [hp_X]/mL CHROMIUM;
  • 15 [hp_C]/mL CLOSTRIDIUM PERFRINGENS;
  • 12 [hp_X]/mL COBALT;
  • 12 [hp_X]/mL COPPER;
  • 12 [hp_X]/mL DYSPROSIUM;
  • 3 [hp_X]/mL ECHINACEA ANGUSTIFOLIA;
  • 12 [hp_X]/mL ERBIUM;
  • 30 [hp_X]/mL ESCHERICHIA COLI;
  • 12 [hp_X]/mL EUROPIUM;
  • 6 [hp_X]/mL EUTROCHIUM PURPUREUM ROOT;
  • 12 [hp_X]/mL GADOLINIUM;
  • 12 [hp_X]/mL GERMANIUM SESQUIOXIDE;
  • 12 [hp_X]/mL GOLD;
  • 12 [hp_X]/mL HOLMIUM;
  • 30 [hp_C]/mL HUMAN HERPESVIRUS 4;
  • 12 [hp_X]/mL INDIUM;
  • 30 [hp_X]/mL INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 30 [hp_X]/mL INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 30 [hp_X]/mL INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 30 [hp_X]/mL INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED);
  • 12 [hp_X]/mL IRON;
  • 14 [hp_C]/mL LANTHANUM;
  • 12 [hp_X]/mL LEAD;
  • 12 [hp_X]/mL LITHIUM CARBONATE;
  • 12 [hp_X]/mL MAGNESIUM;
  • 12 [hp_X]/mL MANGANESE;
  • 30 [hp_X]/mL MEASLES VIRUS;
  • 12 [hp_X]/mL MERCURIC CHLORIDE;
  • 12 [hp_X]/mL MERCURIUS SOLUBILIS;
  • 12 [hp_X]/mL MOLYBDENUM;
  • 12 [hp_X]/mL NEODYMIUM OXIDE;
  • 12 [hp_X]/mL NICKEL;
  • 30 [hp_C]/mL NIOBIUM;
  • 12 [hp_X]/mL OSMIUM;
  • 12 [hp_X]/mL PALLADIUM;
  • 3 [hp_X]/mL PETROSELINUM CRISPUM;
  • 12 [hp_X]/mL PLATINUM;
  • 30 [hp_C]/mL POLIOVIRUS;
  • 8 [hp_X]/mL PORK KIDNEY;
  • 3 [hp_X]/mL POTASSIUM CHLORIDE;
  • 12 [hp_X]/mL PRASEODYMIUM;
  • 30 [hp_X]/mL PROTEUS MORGANII;
  • 30 [hp_X]/mL PROTEUS VULGARIS;
  • 30 [hp_X]/mL PSEUDOMONAS AERUGINOSA;
  • 12 [hp_X]/mL RHODIUM;
  • 12 [hp_X]/mL RUBIDIUM NITRITE;
  • 33 [hp_X]/mL SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI;
  • 12 [hp_X]/mL SAMARIUM;
  • 3 [hp_X]/mL SAW PALMETTO;
  • 12 [hp_X]/mL SELENIUM;
  • 12 [hp_X]/mL SILVER;
  • 3 [hp_X]/mL SOLIDAGO VIRGAUREA FLOWERING TOP;
  • 12 [hp_X]/mL STRONTIUM CARBONATE;
  • 30 [hp_C]/mL TANTALUM;
  • 3 [hp_X]/mL TARAXACUM OFFICINALE;
  • 12 [hp_X]/mL TERBIUM;
  • 12 [hp_X]/mL THALLIUM;
  • 12 [hp_X]/mL TIN;
  • 1 [hp_X]/mL TRITICUM AESTIVUM WHOLE;
  • 12 [hp_X]/mL URANYL NITRATE HEXAHYDRATE;
  • 12 [hp_X]/mL VANADIUM;
  • 12 [hp_X]/mL YTTERBIUM OXIDE;
  • 12 [hp_X]/mL ZINC


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Acetylcholine Release Inhibitor [EPC];
  • Acetylcholine Release Inhibitors [MoA];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Copper [CS];
  • Copper-containing Intrauterine Device [EPC];
  • Decreased Embryonic Implantation [PE];
  • Decreased Sperm Motility [PE];
  • Dietary Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibit Ovum Fertilization [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Mood Stabilizer [EPC];
  • Neuromuscular Blockade [PE];
  • Neuromuscular Blocker [EPC];
  • Non-Standardized Food Allergenic Extract [EPC];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Potassium Compounds [CS];
  • Potassium Salt [EPC];
  • Standardized Chemical Allergen [EPC];
  • Standardized Chemical Allergen [EPC];
  • Standardized Chemical Allergen [EPC];
  • Standardized Chemical Allergen [EPC];
  • Vegetable Proteins [CS]

Labeler Information

Labeler Name: BioActive Nutritional, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:9/13/2019
End Marketing Date:12/3/2024

Package Information

No. Package Code Package Description Billing Unit
143857-0527-130 mL in 1 BOTTLE, DROPPER (43857-0527-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43857-0527The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMERenotoxThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMETriticum Aestivum, Asparagus Officinalis, Berberis Vulgaris, Echinacea (Angustifolia), Kali Muriaticum, Petroselinum Sativum, Sabal Serrulata, Solidago Virgaurea, Taraxacum Officinale, Uva-Ursi, Barosma (Betulina), Eupatorium Purpureum, Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/13/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE12/3/2024This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBioActive Nutritional, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAGATHOSMA BETULINA LEAF; ALUMINUM; ANTIMONY TRISULFIDE; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIOXIDE; ASPARAGUS; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BOTULINUM TOXIN TYPE A; BROMINE; BRYONIA ALBA ROOT; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CLOSTRIDIUM PERFRINGENS; COBALT; COPPER; DYSPROSIUM; ECHINACEA ANGUSTIFOLIA; ERBIUM; ESCHERICHIA COLI; EUROPIUM; EUTROCHIUM PURPUREUM ROOT; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PETROSELINUM CRISPUM; PLATINUM; POLIOVIRUS; PORK KIDNEY; POTASSIUM CHLORIDE; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SAW PALMETTO; SELENIUM; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; TANTALUM; TARAXACUM OFFICINALE; TERBIUM; THALLIUM; TIN; TRITICUM AESTIVUM WHOLE; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH5; 12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 15; 12; 12; 12; 3; 12; 30; 12; 6; 12; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 12; 12; 3; 12; 30; 8; 3; 12; 30; 30; 30; 12; 12; 33; 12; 3; 12; 12; 3; 12; 30; 3; 12; 12; 12; 1; 12; 12; 12; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAcetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Mood Stabilizer [EPC], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023